Underdosing of hydantoin derivatives, initial encounter

This code signifies that a patient has experienced adverse effects due to taking less than the prescribed or recommended dose of a hydantoin derivative medication. This underdosing has occurred for the first time, leading to a new or acute clinical presentation. Hydantoin derivatives are primarily antiepileptic drugs, so underdosing often results in breakthrough seizures or worsening seizure control.

Use this code when documentation clearly indicates that a patient's current symptoms, such as increased seizure frequency or severity, are directly attributable to taking an insufficient amount of their hydantoin-based medication. This applies to initial presentations where the underdosing event is being evaluated and treated for the first time. It is appropriate for situations like a patient forgetting doses, intentionally reducing dosage without medical advice, or having difficulty accessing their medication.

• Ensure the documentation explicitly links the patient's symptoms to the underdosing of a hydantoin derivative.
• Verify that this is the initial encounter for this specific underdosing event, not a subsequent visit for the same issue.
• Always code the specific manifestation of the underdosing (e.g., breakthrough seizure) in addition to this external cause code.